agilon health, inc. (NYSE:AGL) Receives $4.03 Consensus PT from Analysts

agilon health, inc. (NYSE:AGL) has earned a consensus recommendation of “Hold” from the eighteen analysts that are presently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have issued a buy rating on the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $4.03.

AGL has been the subject of several analyst reports. TD Cowen decreased their target price on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research note on Monday, November 11th. Needham & Company LLC initiated coverage on shares of agilon health in a research note on Friday, January 10th. They set a “hold” rating on the stock. JMP Securities lowered agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. Citigroup upgraded agilon health from a “sell” rating to a “neutral” rating and increased their price target for the stock from $1.75 to $2.25 in a research report on Friday, January 10th. Finally, Sanford C. Bernstein upped their target price on agilon health from $2.50 to $3.15 and gave the stock a “market perform” rating in a research note on Wednesday, January 15th.

Insider Buying and Selling at agilon health

In other news, Director Diana Mckenzie purchased 12,500 shares of agilon health stock in a transaction dated Monday, November 25th. The shares were purchased at an average price of $2.28 per share, with a total value of $28,500.00. Following the transaction, the director now owns 51,319 shares in the company, valued at $117,007.32. This represents a 32.20 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director John William Wulf acquired 45,000 shares of the stock in a transaction that occurred on Thursday, December 5th. The stock was acquired at an average price of $2.18 per share, with a total value of $98,100.00. Following the completion of the transaction, the director now directly owns 206,133 shares of the company’s stock, valued at $449,369.94. This trade represents a 27.93 % increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders acquired 90,000 shares of company stock worth $198,100. Insiders own 3.20% of the company’s stock.

Institutional Investors Weigh In On agilon health

A number of institutional investors have recently made changes to their positions in the stock. First Citizens Bank & Trust Co. acquired a new stake in shares of agilon health in the fourth quarter valued at $46,000. Inspire Investing LLC grew its holdings in shares of agilon health by 106.6% in the fourth quarter. Inspire Investing LLC now owns 217,550 shares of the company’s stock valued at $413,000 after purchasing an additional 112,241 shares in the last quarter. Oak Thistle LLC purchased a new stake in agilon health during the 4th quarter worth approximately $25,000. Pines Wealth Management LLC acquired a new stake in shares of agilon health in the fourth quarter valued at $51,000. Finally, JPMorgan Chase & Co. boosted its stake in shares of agilon health by 326.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock valued at $5,563,000 after buying an additional 1,083,492 shares during the period.

agilon health Trading Down 2.3 %

Shares of agilon health stock opened at $3.61 on Friday. The stock has a market cap of $1.49 billion, a PE ratio of -3.84 and a beta of 0.53. The firm has a fifty day moving average price of $2.26 and a 200 day moving average price of $3.54. agilon health has a 1 year low of $1.50 and a 1 year high of $7.73. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.

agilon health (NYSE:AGL) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The company had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same period last year, the firm earned ($0.06) EPS. Equities research analysts predict that agilon health will post -0.59 earnings per share for the current year.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.